Bixiye
QP84-21 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Cholestasis Pruritis
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2021
Natiijooyinka Raadinta
Soo bandhiga 2431 - 2440 ee natiijooyinka 4128
Bixiye
QP85R1-21 Resolution Process for Providers Serving Minnesota Health Care Programs (MHCP) Members
Taariikhda uu dhaqangalayo Barnaamijka: May 11, 2022
Bixiye
QP76-21 Commercial and MHCP Pharmacy Benefit Exclusion for Uptravi®
Taariikhda uu dhaqangalayo barnaamijka: Okt 13, 2021
Bixiye
QP77-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective December 1, 2021
Taariikhda uu dhaqangalayo barnaamijka: Okt 13, 2021
Bixiye
QP78-21 Commercial Pharmacy Benefit Update – New Drug-Related Quantity Limit (QL) Criteria: Stromectol® (ivermectin)
Taariikhda uu dhaqangalayo barnaamijka: Okt 13, 2021
Bixiye
QP79-21 New Availity Appeal Portal Available to Create, Submit and Inquire on Post Service Claim Appeals
Taariikhda uu dhaqangalayo barnaamijka: Okt 13, 2021
Bixiye
P53-21 Update for New-to-Market Medical Drug: aducanumab (Aduhelm)
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021
Bixiye
2021 October Bulletins
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2021
Bixiye
Cablivi (caplacizumab-yhdp) - Medicaid
Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025